ALIM - Alimera Sciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.30
0.00 (0.00%)
As of 10:41AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close1.30
Open1.30
Bid1.28 x 400
Ask1.29 x 200
Day's Range1.27 - 1.30
52 Week Range1.06 - 1.72
Volume20,368
Avg. Volume175,210
Market Cap89.893M
Beta2.70
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    ETFs with exposure to Alimera Sciences, Inc. : December 8, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube20 days ago

    ETFs with exposure to Alimera Sciences, Inc. : November 21, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Alimera Sciences, Inc. : November 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 8, 2017
    Capital Cubelast month

    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 8, 2017

    Categories: Yahoo FinanceGet free summary analysis Alimera Sciences, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Alimera Sciences, Inc. – pSivida Corp. and Insmed Incorporated (PSDV-US and INSM-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 9.78 million, Net ... Read more (Read more...)

  • Thomson Reuters StreetEventslast month

    Edited Transcript of ALIM earnings conference call or presentation 2-Nov-17 1:00pm GMT

    Q3 2017 Alimera Sciences Inc Earnings Call

  • Associated Presslast month

    Alimera Sciences reports 3Q loss

    On a per-share basis, the Alpharetta, Georgia-based company said it had a loss of 8 cents. Losses, adjusted for non-recurring costs, came to 4 cents per share. The eye drug developer posted revenue of ...

  • Capital Cube2 months ago

    ETFs with exposure to Alimera Sciences, Inc. : October 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to Alimera Sciences, Inc. : September 29, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to Alimera Sciences, Inc. : September 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017
    Capital Cube3 months ago

    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017

    Categories: Yahoo FinanceGet free summary analysis Alimera Sciences, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Alimera Sciences, Inc. – Ophthotech Corp., Eleven Biotherapeutics, Inc., Aerie Pharmaceuticals, Inc., Mateon Therapeutics, Inc., Regeneron Pharmaceuticals, Inc. and Insmed Incorporated (OPHT-US, EBIO-US, AERI-US, MATN-US, REGN-US and INSM-US) ... Read more (Read more...)

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of ALIM earnings conference call or presentation 3-Aug-17 1:00pm GMT

    Q2 2017 Alimera Sciences Inc Earnings Call

  • Associated Press4 months ago

    Alimera Sciences reports 2Q loss

    On a per-share basis, the Alpharetta, Georgia-based company said it had a loss of 4 cents. The eye drug developer posted revenue of $10.4 million in the period. The company's shares closed at $1.42. A ...

  • Capital Cube5 months ago

    ETFs with exposure to Alimera Sciences, Inc. : July 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Zacks5 months ago

    The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences

    The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences

  • Zacks5 months ago

    5 Top Multibagger Biotech Stocks to Buy in the 2nd Half

    Draconian crackdown on drug prices easing out and likelihood of a series of buyouts will help innovation starved biotech companies to gain in the second half.

  • Capital Cube5 months ago

    ETFs with exposure to Alimera Sciences, Inc. : June 29, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube6 months ago

    ETFs with exposure to Alimera Sciences, Inc. : June 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
    Capital Cube6 months ago

    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017

    Categories: Yahoo FinanceGet free summary analysis Alimera Sciences, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Alimera Sciences, Inc. – Ophthotech Corp., pSivida Corp., Mateon Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., Insmed Incorporated, Eleven Biotherapeutics, Inc. and Aerie Pharmaceuticals, Inc. (OPHT-US, PSDV-US, MATN-US, REGN-US, INSM-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents7 months ago

    Edited Transcript of ALIM earnings conference call or presentation 9-May-17 12:00pm GMT

    Q1 2017 Alimera Sciences Inc Earnings Call

  • Associated Press7 months ago

    Alimera Sciences reports 1Q loss

    The Alpharetta, Georgia-based company said it had a loss of 10 cents per share. The eye drug developer posted revenue of $6.6 million in the period. In the final minutes of trading on Monday, the company's ...

  • Capital Cube7 months ago

    ETFs with exposure to Alimera Sciences, Inc. : May 1, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube8 months ago

    ETFs with exposure to Alimera Sciences, Inc. : April 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cube9 months ago

    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis Alimera Sciences, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Alimera Sciences, Inc. – Ophthotech Corp., pSivida Corp., Regeneron Pharmaceuticals, Inc., Insmed Incorporated and Aerie Pharmaceuticals, Inc. (OPHT-US, PSDV-US, REGN-US, INSM-US and AERI-US) that have also reported for ... Read more (Read more...)

  • Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
    Capital Cube9 months ago

    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017

    Categories: Yahoo Finance Get free summary analysis Alimera Sciences, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Alimera Sciences, Inc. – Ophthotech Corp., pSivida Corp., Regeneron Pharmaceuticals, Inc., Insmed Incorporated and Aerie Pharmaceuticals, Inc. (OPHT-US, PSDV-US, REGN-US, INSM-US and AERI-US) that have also reported for ... Read more (Read more...)

  • Alimera Sciences, Inc. (ALIM) Looks Good: Stock Up 12.8%
    Zacks9 months ago

    Alimera Sciences, Inc. (ALIM) Looks Good: Stock Up 12.8%

    Alimera Sciences, Inc. (ALIM) shares rise almost 13% in the last trading session.